Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.15
+0.22 (3.71%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pulmonx Revenue
Pulmonx had revenue of $20.39M in the quarter ending September 30, 2024, with 15.39% growth. This brings the company's revenue in the last twelve months to $79.30M, up 22.34% year-over-year. In the year 2023, Pulmonx had annual revenue of $68.68M with 27.98% growth.
Revenue (ttm)
$79.30M
Revenue Growth
+22.34%
P/S Ratio
3.01
Revenue / Employee
$284,237
Employees
279
Market Cap
242.85M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
High Tide | 370.02M |
Anika Therapeutics | 164.17M |
Heron Therapeutics | 137.74M |
Electromed | 57.06M |
BGM Group | 29.87M |
Artiva Biotherapeutics | 2.60M |
Cardiff Oncology | 688.00K |
LUNG News
- 4 weeks ago - Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Business Wire
- 6 weeks ago - Pulmonx to Present at the Stifel 2024 Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 - GlobeNewsWire
- 3 months ago - Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 - GlobeNewsWire
- 4 months ago - Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference - GlobeNewsWire
- 4 months ago - Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference - GlobeNewsWire